Home » Topics » Regulatory

Regulatory
RSS

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Mentax approved for two new indications by FDA

Jan. 7, 1997

FDA clears Rogaine generic

Jan. 3, 1997

Procrit cleared for new indication

Jan. 3, 1997

New HRT patch approved for launch in U.S.

Jan. 3, 1997

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

Watson's first NDA product approved

Jan. 3, 1997

Two FDA approvals for Taro

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...